OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial
Stine Brændegaard Winther, Gábor Liposits, Halla Skúladóttir, et al.
The Lancet. Gastroenterology & hepatology (2019) Vol. 4, Iss. 5, pp. 376-388
Closed Access | Times Cited: 55
Stine Brændegaard Winther, Gábor Liposits, Halla Skúladóttir, et al.
The Lancet. Gastroenterology & hepatology (2019) Vol. 4, Iss. 5, pp. 376-388
Closed Access | Times Cited: 55
Showing 1-25 of 55 citing articles:
Chemotherapy-Related Toxic Effects and Quality of Life and Physical Functioning in Older Patients
Joosje C. Baltussen, Nienke A. de Glas, Yara van Holstein, et al.
JAMA Network Open (2023) Vol. 6, Iss. 10, pp. e2339116-e2339116
Open Access | Times Cited: 22
Joosje C. Baltussen, Nienke A. de Glas, Yara van Holstein, et al.
JAMA Network Open (2023) Vol. 6, Iss. 10, pp. e2339116-e2339116
Open Access | Times Cited: 22
Metastatic colorectal cancer: Advances in the folate-fluoropyrimidine chemotherapy backbone
Bengt Glimelius, Sebastian Stintzing, John L. Marshall, et al.
Cancer Treatment Reviews (2021) Vol. 98, pp. 102218-102218
Open Access | Times Cited: 48
Bengt Glimelius, Sebastian Stintzing, John L. Marshall, et al.
Cancer Treatment Reviews (2021) Vol. 98, pp. 102218-102218
Open Access | Times Cited: 48
Consequences of a high incidence of microsatellite instability and BRAF‐mutated tumors: A population‐based cohort of metastatic colorectal cancer patients
Kristine Aasebø, Anca Dragomir, Magnus Sundström, et al.
Cancer Medicine (2019) Vol. 8, Iss. 7, pp. 3623-3635
Open Access | Times Cited: 46
Kristine Aasebø, Anca Dragomir, Magnus Sundström, et al.
Cancer Medicine (2019) Vol. 8, Iss. 7, pp. 3623-3635
Open Access | Times Cited: 46
Time toxicity among older patients with cancer treated with palliative systemic therapy
Joosje C. Baltussen, Paula Cárdenas-Reyes, Yanin Chávarri-Guerra, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 9
Closed Access | Times Cited: 5
Joosje C. Baltussen, Paula Cárdenas-Reyes, Yanin Chávarri-Guerra, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 9
Closed Access | Times Cited: 5
Severe fluoropyrimidine toxicity in older adults with cancer with DPYD wild type
Edwin J. Brokaar, Jonathan E. Knikman, Loes E. Visser, et al.
Fundamental and Clinical Pharmacology (2025) Vol. 39, Iss. 2
Open Access
Edwin J. Brokaar, Jonathan E. Knikman, Loes E. Visser, et al.
Fundamental and Clinical Pharmacology (2025) Vol. 39, Iss. 2
Open Access
Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study
Pia Österlund, S. Kinos, Per Pfeiffer, et al.
ESMO Open (2022) Vol. 7, Iss. 3, pp. 100427-100427
Open Access | Times Cited: 21
Pia Österlund, S. Kinos, Per Pfeiffer, et al.
ESMO Open (2022) Vol. 7, Iss. 3, pp. 100427-100427
Open Access | Times Cited: 21
Age disparities in stage‐specific colon cancer survival across seven countries: An International Cancer Benchmarking Partnership SURVMARK ‐2 population‐based study
Sophie Pilleron, Hadrien Charvat, Marzieh Araghi, et al.
International Journal of Cancer (2020) Vol. 148, Iss. 7, pp. 1575-1585
Open Access | Times Cited: 30
Sophie Pilleron, Hadrien Charvat, Marzieh Araghi, et al.
International Journal of Cancer (2020) Vol. 148, Iss. 7, pp. 1575-1585
Open Access | Times Cited: 30
Physical decline, falls, and hospitalization among vulnerable older patients in the trajectory of colorectal cancer treatment
Cecilia Margareta Lund, Dorte Nielsen, Martin Schultz, et al.
Journal of Geriatric Oncology (2024) Vol. 15, Iss. 7, pp. 101820-101820
Closed Access | Times Cited: 3
Cecilia Margareta Lund, Dorte Nielsen, Martin Schultz, et al.
Journal of Geriatric Oncology (2024) Vol. 15, Iss. 7, pp. 101820-101820
Closed Access | Times Cited: 3
Frailty screening for predicting rapid functional decline, rapid progressive disease, and shorter overall survival in older patients with gastrointestinal cancer receiving palliative chemotherapy - a prospective, clinical study
Eva Jespersen, Stine Brændegaard Winther, Lisbeth Kirstine Rosenbek Minet, et al.
Journal of Geriatric Oncology (2020) Vol. 12, Iss. 4, pp. 578-584
Open Access | Times Cited: 27
Eva Jespersen, Stine Brændegaard Winther, Lisbeth Kirstine Rosenbek Minet, et al.
Journal of Geriatric Oncology (2020) Vol. 12, Iss. 4, pp. 578-584
Open Access | Times Cited: 27
Resectability, Resections, Survival Outcomes, and Quality of Life in Older Adult Patients with Metastatic Colorectal Cancer (the RAXO-Study)
Kaisa Lehtomäki, Leena‐Maija Soveri, Emerik Österlund, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 10, pp. 3541-3541
Open Access | Times Cited: 8
Kaisa Lehtomäki, Leena‐Maija Soveri, Emerik Österlund, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 10, pp. 3541-3541
Open Access | Times Cited: 8
Quality of Life in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy—The Randomized NORDIC9-Study
Gábor Liposits, Henrik Eshøj, Søren Møller, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2604-2604
Open Access | Times Cited: 18
Gábor Liposits, Henrik Eshøj, Søren Møller, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2604-2604
Open Access | Times Cited: 18
Development and validation of survival nomograms in colorectal cancer patients with synchronous liver metastases underwent simultaneous surgical treatment of primary and metastatic lesions.
Xiao Guo, Yang Liu, Lujia Liu, et al.
(2021) Vol. 11, Iss. 6, pp. 2654-2669
Closed Access | Times Cited: 18
Xiao Guo, Yang Liu, Lujia Liu, et al.
(2021) Vol. 11, Iss. 6, pp. 2654-2669
Closed Access | Times Cited: 18
Chemotherapy Toxicity in Older Adults Optimized by Geriatric Assessment and Intervention: A Non-Comparative Analysis
Munzir Hamid, Michelle Hannan, Nay Myo Oo, et al.
Current Oncology (2022) Vol. 29, Iss. 9, pp. 6167-6176
Open Access | Times Cited: 11
Munzir Hamid, Michelle Hannan, Nay Myo Oo, et al.
Current Oncology (2022) Vol. 29, Iss. 9, pp. 6167-6176
Open Access | Times Cited: 11
Update on the management of elderly patients with colorectal cancer
Gemma Soler-González, Javier Sastre-Valera, Antônio Brazil Viana, et al.
Clinical & Translational Oncology (2023) Vol. 26, Iss. 1, pp. 69-84
Open Access | Times Cited: 6
Gemma Soler-González, Javier Sastre-Valera, Antônio Brazil Viana, et al.
Clinical & Translational Oncology (2023) Vol. 26, Iss. 1, pp. 69-84
Open Access | Times Cited: 6
The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy—The Randomized NORDIC9-Study
Gábor Liposits, Halla Skúladóttir, Jesper Ryg, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 19, pp. 5603-5603
Open Access | Times Cited: 10
Gábor Liposits, Halla Skúladóttir, Jesper Ryg, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 19, pp. 5603-5603
Open Access | Times Cited: 10
Prediction of Chemotoxicity, Unplanned Hospitalizations and Early Death in Older Patients with Colorectal Cancer Treated with Chemotherapy
Jaime Feliú, Enrique Espinosa, Laura Basterretxea, et al.
Cancers (2021) Vol. 14, Iss. 1, pp. 127-127
Open Access | Times Cited: 14
Jaime Feliú, Enrique Espinosa, Laura Basterretxea, et al.
Cancers (2021) Vol. 14, Iss. 1, pp. 127-127
Open Access | Times Cited: 14
The impact of timely cancer diagnosis on age disparities in colon cancer survival
Sophie Pilleron, Camille Maringe, Hadrien Charvat, et al.
Journal of Geriatric Oncology (2021) Vol. 12, Iss. 7, pp. 1044-1051
Open Access | Times Cited: 13
Sophie Pilleron, Camille Maringe, Hadrien Charvat, et al.
Journal of Geriatric Oncology (2021) Vol. 12, Iss. 7, pp. 1044-1051
Open Access | Times Cited: 13
Combination of the G-8 Screening Tool and Hand-Grip Strength to Predict Long-Term Overall Survival in Non-Small Cell Lung Cancer Patients Undergoing Stereotactic Body Radiotherapy
Kristian Kirkelund Bentsen, Olfred Hansen, Jesper Ryg, et al.
Cancers (2021) Vol. 13, Iss. 13, pp. 3363-3363
Open Access | Times Cited: 11
Kristian Kirkelund Bentsen, Olfred Hansen, Jesper Ryg, et al.
Cancers (2021) Vol. 13, Iss. 13, pp. 3363-3363
Open Access | Times Cited: 11
Time trends in treatment patterns and survival of older patients with synchronous metastatic colorectal cancer in the Netherlands: A population‐based study
Joosje C. Baltussen, Nienke A. de Glas, Gerrit‐Jan Liefers, et al.
International Journal of Cancer (2023) Vol. 152, Iss. 10, pp. 2043-2051
Open Access | Times Cited: 4
Joosje C. Baltussen, Nienke A. de Glas, Gerrit‐Jan Liefers, et al.
International Journal of Cancer (2023) Vol. 152, Iss. 10, pp. 2043-2051
Open Access | Times Cited: 4
Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study)
Sampsa Kinos, Helga Hagman, Päivi Halonen, et al.
Acta Oncologica (2024) Vol. 63, pp. 248-258
Open Access | Times Cited: 1
Sampsa Kinos, Helga Hagman, Päivi Halonen, et al.
Acta Oncologica (2024) Vol. 63, pp. 248-258
Open Access | Times Cited: 1
How to Balance Prognostic Factors in Controlled Phase II Trials: Stratified Permuted Block Randomization or Minimization? An Analysis of Clinical Trials in Digestive Oncology
E. Martin, Karine Le Malicot, Catherine Guérin‐Charbonnel, et al.
Current Oncology (2024) Vol. 31, Iss. 6, pp. 3513-3528
Open Access | Times Cited: 1
E. Martin, Karine Le Malicot, Catherine Guérin‐Charbonnel, et al.
Current Oncology (2024) Vol. 31, Iss. 6, pp. 3513-3528
Open Access | Times Cited: 1
DOSAGE study: protocol for a phase III non-inferiority randomised trial investigating dose-reduced chemotherapy for advanced colorectal cancer in older patients
Joosje C. Baltussen, Frederiek van den Bos, Marije Slingerland, et al.
BMJ Open (2024) Vol. 14, Iss. 8, pp. e089882-e089882
Open Access | Times Cited: 1
Joosje C. Baltussen, Frederiek van den Bos, Marije Slingerland, et al.
BMJ Open (2024) Vol. 14, Iss. 8, pp. e089882-e089882
Open Access | Times Cited: 1
Neutrophil-to-lymphocyte Ratio as a Prognostic Factor for Colon Cancer in Elderly Patients: A Propensity Score Analysis
Junichi Mazaki, Kenji Katsumata, Hiroki Sujino, et al.
Anticancer Research (2021) Vol. 41, Iss. 9, pp. 4471-4478
Open Access | Times Cited: 10
Junichi Mazaki, Kenji Katsumata, Hiroki Sujino, et al.
Anticancer Research (2021) Vol. 41, Iss. 9, pp. 4471-4478
Open Access | Times Cited: 10
Predictive value of geriatric oncology screening and geriatric assessment of older patients with cancer: A randomized clinical trial protocol (PROGNOSIS-RCT)
Ann-Kristine Weber Giger, Helena Møgelbjerg Ditzel, Trine Lembrecht Jørgensen, et al.
Journal of Geriatric Oncology (2021) Vol. 13, Iss. 1, pp. 116-123
Open Access | Times Cited: 9
Ann-Kristine Weber Giger, Helena Møgelbjerg Ditzel, Trine Lembrecht Jørgensen, et al.
Journal of Geriatric Oncology (2021) Vol. 13, Iss. 1, pp. 116-123
Open Access | Times Cited: 9
A phase II study of daily encorafenib in combination with biweekly cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: the NEW BEACON study
Martina Eriksen, Per Pfeiffer, Kristoffer Rohrberg, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Martina Eriksen, Per Pfeiffer, Kristoffer Rohrberg, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 6
